Our studies showed that NF-κB activation plays vital roles in the development and progression of ESCC, and NF-κB pathway blockade can inhibit proliferation and suppress angiogenesis and metastasis in ESCC. Here, NFKB1 is linked to esophageal squamous cell carcinoma.